palmitoylethanolamide.com.au
HomeResearchIraj 2015

Palmitoylethanolamide attenuates PTZ-induced seizures through CB1 and CB2 receptors

Iraj Aghaei, Mohammad Rostampour, Mohammad Shabani, Nima Naderi, Fereshteh Motamedi, Parvin Babaei, Behrooz Khakpour-Taleghani. Epilepsy Res. 2015;117:23-8.

Laboratory studyOther animals

Design
Laboratory study
Subjects
Male Wistar rats with pentylenetetrazol (PTZ) chemical kindling
Dose used in the study
PEA given with or without the CB1 antagonist AM251 or the CB2 antagonist AM630
Duration
Not stated in the abstract
What was measured
Latency to seizure onset, seizure stage, and latency and duration of the fifth (most severe) seizure stage.

What the authors reported

PEA increased the time to seizure onset and shortened seizure duration after PTZ injection. AM251 had opposite effects depending on dose, AM630 worsened seizures in a dose-dependent way, and combining both antagonists reduced PEA's protective effect, though PEA remained partly effective.

Limits of this study

A rat model of chemically induced seizures; it cannot show effect in people with epilepsy. Funding and conflicts not stated in the abstract.

Source

PubMed 26370914 · doi:10.1016/j.eplepsyres.2015.08.010

Entry checked against the abstract on PubMed on 2026-09-22. The dose shown is the dose the researchers used. It is not a recommendation. How to read this page.